sterna biologicals to attend international partnering and investor conferences in November
Marburg, Germany, November 07, 2019
Sterna biologicals GmbH & Co. KG (“sterna”), an innovative clinical-stage immunology company developing novel treatments for chronic inflammatory diseases, today announced that the Company will participate and present at the following partnering and investor conferences in November: